MEN1 and breast neuroendocrine neoplasm: The results indicated that the MEN1 gene had the most significantly different pathogenetic or unknown variant rates in the patients of the two cohorts, being mutated in 36 out of 98 (36.7%) PNET samples in comparison to only 3 out of 53 (5.7%) breast NET samples (adjusted p value 0.00050).